In a similar work, a DNA-chimeric siRNA was generated against Plk1, which was more stable in human serum than nonchimeric siRNA and the chimeric Plk1-siRNA inhibited malignant mesothelioma (MM) cell proliferation through the induction of apoptosis in vitro. The gene discussed is PLK1; the disease is Miyoshi myopathy.